Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Akebia Therapeutics (AKBA) over the last 10 years, with Q3 2025 value amounting to -$10000.0.

  • Akebia Therapeutics' Non Operating Income rose 4117.65% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $230000.0, marking a year-over-year decrease of 6700.14%. This contributed to the annual value of $94000.0 for FY2024, which is 8940.25% down from last year.
  • Per Akebia Therapeutics' latest filing, its Non Operating Income stood at -$10000.0 for Q3 2025, which was up 4117.65% from -$28000.0 recorded in Q2 2025.
  • Over the past 5 years, Akebia Therapeutics' Non Operating Income peaked at $1.3 million during Q2 2021, and registered a low of -$43000.0 during Q3 2023.
  • For the 5-year period, Akebia Therapeutics' Non Operating Income averaged around $353421.1, with its median value being $213000.0 (2025).
  • As far as peak fluctuations go, Akebia Therapeutics' Non Operating Income surged by 60434.78% in 2022, and later plummeted by 29000.0% in 2024.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Non Operating Income stood at $560000.0 in 2021, then fell by 22.5% to $434000.0 in 2022, then skyrocketed by 51.61% to $658000.0 in 2023, then tumbled by 91.64% to $55000.0 in 2024, then plummeted by 118.18% to -$10000.0 in 2025.
  • Its Non Operating Income stands at -$10000.0 for Q3 2025, versus -$28000.0 for Q2 2025 and $213000.0 for Q1 2025.